Skip to main content
Screener/Healthcare/Biotechnology

APRE Aprea Therapeutics, Inc.

NASDAQ
$0.81+0.02 (+2.03%)
$0.55
$2.22
$0.79
$0.85
EPS (TTM)$-1.75
P/E Ratio-0.51
Dividend Yield
Market Cap$5.4M
Volume121K
Prev Close$0.79
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$3.3M$-0.43
Q4 '25$3K-$2.5M$-0.32131325.4%-73588.0%
Q3 '25$2K-$3.0M$-0.47-193.8%-160844.7%
Q2 '25$118K-$3.2M$-0.53-1519.0%-2742.2%
Q1 '25$162K-$3.9M$-0.66-1428.4%-2420.6%
Q4 '24$206K-$2.9M$-0.49-1046.2%-1406.5%
Q3 '24$355K-$3.8M$-0.64-702.7%-1067.0%
Q2 '24$562K-$3.5M$-0.58-355.4%-617.9%
Get Your Daily Market Recap